SEC Form 4 · accession 0000905718-17-001034
Zomedica Corp. · ZOMDF
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Gerald Solensky Jr.
Officer — President and CEO · Director · 10% Owner
Period of report
Dec 19, 2017
Accepted (ET)
Dec 19, 2017 · 7:36 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001684144
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Shares, without par value | Dec 19, 2017 | M | 750,000 | $1.20 | A | 37,951,100 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $1.20 | Dec 19, 2017 | M | 750,000 | D | Dec 21, 2016 | Dec 21, 2018 | Common Shares, without par value | 750,000 | 200,000 | D |
Explanation of responses
- F1The options vested upon grant. The option is currently fully vested.